GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Gene Technology Ltd (ASX:BGT) » Definitions » Other Income (Expense)

Bio-Gene Technology (ASX:BGT) Other Income (Expense) : A$0.54 Mil (TTM As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Bio-Gene Technology Other Income (Expense)?

Bio-Gene Technology's other income expense for the Bio-Gene Technology's pretax income for the six months ended in Dec. 2024 was A$0.03 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2024 was A$0.54 Mil.

Bio-Gene Technology Other Income (Expense) Historical Data

The historical data trend for Bio-Gene Technology's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Gene Technology Other Income (Expense) Chart

Bio-Gene Technology Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Income (Expense)
Get a 7-Day Free Trial 0.17 0.03 0.01 - 0.61

Bio-Gene Technology Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 -0.04 0.10 0.50 0.03

Bio-Gene Technology Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Gene Technology  (ASX:BGT) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Bio-Gene Technology Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Gene Technology Ltd (ASX:BGT) » Definitions » Other Income (Expense)
Comparable Companies
ASX:IXC ASX:CMB ASX:VBS ASX:ZLD ASX:BIT ASX:PAB ASX:1AD ASX:NSB ASX:CHM ASX:1AI VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
400 Collins Street, Level 6, Melbourne, VIC, AUS, 3000
Website
https://www.bio-gene.com.au
Bio-Gene Technology Ltd is an Australian company developing novel bio-insecticides to address the challenges of insecticide resistance. Its products are Flavocide and Qcide which include a naturally occurring class of compounds to overcome resistance to control pests with minimal impact on human health and the environment. The group's product has multiple applications across public health, crop protection, grain storage, and consumer use. It provides new options derived from nature to meet market demand for effective and safe pest management solutions.

Bio-Gene Technology Headlines

From GuruFocus

Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds

By Business Wire Business Wire • 12-20-2021

BlackRock Floating Rate Income Trust (BGT) Maintains Monthly Dividend Payout

By GuruFocus News • 04-02-2025